title: Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
abstract: BACKGROUND
  Hyperlipoproteinemia is occasionally associated with severe glomerular injury caused by abnormal accumulation of lipid in glomeruli, which occurs in conditions such as lipoprotein glomerulopathy (LPG). This study investigates the cases of two siblings with homozygous apolipoprotein (apo) E2 who show unique histologic features, massive proteinuria, and dysbetalipoproteinemia.
  
  
  METHODS
  Histologic studies were performed using renal biopsy specimens. Plasma lipoproteins were extensively characterized. The exons of the apo E genes were sequenced to avoid missing any mutations.
  
  
  RESULTS
  Histologically, the siblings' condition resembled LPG by light microscopy studies. Electron microscopy studies revealed large lipoid deposits in the paramesangium, subendothelium, and subepithelium of the glomeruli, which were different from LPG in terms of not forming the layered structure resembling a fingerprint even in large lipoprotein thrombi, and mesangial foam cells. Immunohistochemically, the lipoid deposits contained apo E and apo B. These patients did not have either diabetic nephropathy or other known forms of glomerulonephritis. The sequence of exons of the apo E genes revealed homozygosity for apo E2 in both cases.
  
  
  CONCLUSIONS
  The extensive lipoprotein deposition in glomeruli, which resembles LPG, can also occur in apo E2 homozygous individuals, but in a distinct fashion. Because the two cases were siblings, they may have other shared alleles, in addition to the apo E2 allele, that negatively affect processing of lipoproteins and lead to abnormal accumulation of lipoprotein deposits in glomeruli.
authors.affiliation: Department of Medicine (II), Niigata University School of Medicine, Niigata, Japan. sakatsum@med.niigata-u.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Sakatsume
authors.forename: M
authors.initials: M
authors.lastname: Kadomura
authors.forename: I
authors.initials: I
authors.lastname: Sakata
authors.forename: N
authors.initials: N
authors.lastname: Imai
authors.forename: D
authors.initials: D
authors.lastname: Kondo
authors.forename: Y
authors.initials: Y
authors.lastname: Osawa
authors.forename: H
authors.initials: H
authors.lastname: Shimada
authors.forename: M
authors.initials: M
authors.lastname: Ueno
authors.forename: T
authors.initials: T
authors.lastname: Miida
authors.forename: S
authors.initials: S
authors.lastname: Nishi
authors.forename: M
authors.initials: M
authors.lastname: Arakawa
authors.forename: F
authors.initials: F
authors.lastname: Gejyo
mesh_terms: D000595:Amino Acid Sequence; D053329:Apolipoprotein E2; D001057:Apolipoproteins E / Q000235:genetics*; D001483:Base Sequence; D004247:DNA / Q000235:genetics; D004252:DNA Mutational Analysis; D017931:DNA Primers / Q000235:genetics; D005260:Female; D005838:Genotype; D006720:Homozygote; D006801:Humans; D006951:Hyperlipoproteinemias / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D007674:Kidney Diseases / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D007678:Kidney Glomerulus / Q000378:metabolism* / Q000473:pathology; D008074:Lipoproteins / Q000235:genetics* / Q000378:metabolism*; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D010641:Phenotype
chemical_list: D053329:Apolipoprotein E2; D001057:Apolipoproteins E; D017931:DNA Primers; D008074:Lipoproteins; D004247:DNA